iOnctura

Showing 1 posts of 1 posts found.

iOnctura expands clinical trial programme for NSCLC

July 9, 2024
Research and Development NSCLC, Oncology, clinical trial, iOnctura, lung cancer

iOnctura has announced the expansion of its clinical trial programme for its lead pipeline asset, roginolisib.

The Gateway to Local Adoption Series

Latest content